Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Argos Therapeutics (ARGS)

0.1558 0.008 (5.27%)

12-15 16:00

Open:

0.1548

Pre. Close:

0.148

High:

0.16

Low:

0.151

Volume:

2,430,370

Market Cap:

14M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.16 - 0.17

0.17 - 0.17

Low:

0.15 - 0.15

0.15 - 0.15

Close:

0.16 - 0.16

0.16 - 0.17

Technical analysis  (as of: 2017-12-15 4:53:12 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 0.27     One year: 0.34

Support:

Support1: 0.14    Support2: 0.12

Resistance:

Resistance1: 0.23    Resistance2: 0.29

Pivot:

0.16

Moving Averages:

MA(5): 0.15     MA(20): 0.17

MA(100): 0.19     MA(250): 1.14

MACD:

MACD(12,26): -0.01     Signal(12,26,9):

%K %D:

%K(14,3): 14.61     %D(3): 9.77

RSI:

RSI(14): 43.97

52-Week:

High: 5.683  Low: 0.131  Change(%): -96.8

Average Vol(K):

3-Month: 550405  10-Days 270318

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ARGS has closed above bottom band by 34.7%. Bollinger Bands are 34.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 15 Dec 2017 16:30:00 GMT
Which Way Traders Signposts Sunrun Inc. (RUN), Argos Therapeutics, Inc. (ARGS ...

Tue, 12 Dec 2017 22:30:05 GMT
Argos Therapeutics Inc. (ARGS) Plunges 7.24% on December 12

Fri, 08 Dec 2017 17:37:30 GMT
Few Things investors Didn't Know About: Argos Therapeutics, Inc. (ARGS), The ...

Tue, 12 Dec 2017 12:56:15 GMT
Hot Tickers: Argos Therapeutics, Inc. (ARGS), Exact Sciences Corporation (EXAS)

Tue, 05 Dec 2017 18:45:00 GMT
Just the Facts on Argos Therapeutics, Inc. (ARGS)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

87.88

Shares Float (M)

53.02

% Held by Insiders

24.35

% Held by Institutions

6.73

Shares Short (K)

7360

Shares Short Prior Month (K)

5590

Stock Financials

EPS

-1.185

EPS Est. Current Year

-1.190

EPS Est. Next Year

-0.480

EPS Est. Next Quarter

-0.200

Forward EPS

-0.347

Book Value (p.s.)

-0.220

PEG Ratio

Profit Margin

Operating Margin

-10366.05

Return on Assets (ttm)

-37.8

Return on Equity (ttm)

-3419.6

Qtrly Rev. Growth

-63.5

Gross Profit (p.s.)

0.011

Sales Per Share

EBITDA (p.s.)

-0.451

Qtrly Earnings Growth

Operating Cash Flow (M)

-40.73

Levered Free Cash Flow (M)

-39.52

atoplab.com

Valuation

P/E

-0.13

P/E Growth Ratio

0.05

P/BV

-0.71

P/S

1369170432.00

P/CF

-0.34

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.